Pediatric Patients with Cannabis Use Disorder Had Higher Rates of Urinary Symptoms

Among nearly 5 million matched pediatric patients, those with cannabis use disorder had significantly higher rates of pelvic pain, overactive bladder, dysuria, and urinary tract infections over five years.

Grutman, Aurora J et al.·Urology·2025·Moderate EvidenceRetrospective Cohort
RTHC-06594Retrospective CohortModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Retrospective Cohort
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

After propensity score matching over 4.8 million male and 4.2 million female patients under 18, those with CUD showed significantly higher rates of new urinary symptom diagnoses at 5-year follow-up. Female CUD patients had elevated rates of pelvic pain (OR 2.3), overactive bladder (OR 1.6), dysuria (OR 1.2), and UTI (OR 1.8). Male CUD patients showed increased pelvic pain (OR 3.8), dysuria (OR 1.4), and UTI (OR 1.7).

Key Numbers

~9.1 million patients screened; 11,840 matched males and 11,810 matched females per arm; median age ~15.5 years; female CUD: pelvic pain OR 2.3, OAB OR 1.6, UTI OR 1.8; male CUD: pelvic pain OR 3.8, UTI OR 1.7

How They Did This

Retrospective cohort study using the TriNetX Research Network. Male and female patients under 18 with or without CUD were propensity score matched for demographics and comorbidities. Primary outcomes: new diagnoses of LUTS, pelvic pain, overactive bladder, dysuria, or UTI at 5-year follow-up.

Why This Research Matters

Urinary symptoms in adolescents are rarely discussed in the context of cannabis use. This large database study suggests an underrecognized association that could inform clinical screening and patient counseling.

The Bigger Picture

Cannabinoid receptors are present throughout the urinary tract, providing a biological basis for these associations. As adolescent cannabis use increases, clinicians evaluating urinary symptoms in teens should consider cannabis use history.

What This Study Doesn't Tell Us

Administrative database cannot confirm actual cannabis use patterns. CUD diagnosis codes may capture severe cases only. Cannot determine causality. Propensity matching cannot account for unmeasured confounders. UTI association may reflect behavioral rather than physiological factors.

Questions This Raises

  • ?Through what mechanism might cannabinoids affect lower urinary tract function?
  • ?Would cannabis cessation improve urinary symptoms in affected adolescents?

Trust & Context

Key Stat:
Evidence Grade:
Moderate: very large matched cohort with 5-year follow-up, but administrative database with inherent limitations.
Study Age:
2025 publication
Original Title:
Cannabis Use is Associated With Lower Urinary Tract Symptoms in Pediatric Patients-A Large Claims Database Study.
Published In:
Urology, 205, 187-195 (2025)
Database ID:
RTHC-06594

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Looks back at existing records to find patterns.

What do these levels mean? →

Read More on RethinkTHC

Cite This Study

RTHC-06594·https://rethinkthc.com/research/RTHC-06594

APA

Grutman, Aurora J; Gumma, Mohammad Elmojtaba; Page, Nicole; Gabrielson, Andrew T; Clifton, Marisa; DiCarlo, Heather. (2025). Cannabis Use is Associated With Lower Urinary Tract Symptoms in Pediatric Patients-A Large Claims Database Study.. Urology, 205, 187-195. https://doi.org/10.1016/j.urology.2025.07.014

MLA

Grutman, Aurora J, et al. "Cannabis Use is Associated With Lower Urinary Tract Symptoms in Pediatric Patients-A Large Claims Database Study.." Urology, 2025. https://doi.org/10.1016/j.urology.2025.07.014

RethinkTHC

RethinkTHC Research Database. "Cannabis Use is Associated With Lower Urinary Tract Symptoms..." RTHC-06594. Retrieved from https://rethinkthc.com/research/grutman-2025-cannabis-use-is-associated

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.